Third-quarter revenues for Mazor Robotics (NSDQ:MZOR) are expected to slide nearly 27%, the Israeli medical device company said, adding that it’s planning an offering of up to 2.3 million shares of its stock.
Mazor said its preliminary earnings report for the 3 months ended Sept. 30 indicates that revenues will be about $3.0 million, down 26.8% compared with the $4.1 million posted during Q3 2012.
Caesarea, Israel-based Mazor said it sold 2 of its Renaissance surgical robots for spinal procedures and 1 upgrade during the quarter, compared with 5 systems sold during the same period last year.
The news sent MZOR shares down 11.0% to $18.37 apiece as of about 11:15 a.m. today.
Mazor also said it’s planning a public offering of 2 million shares of stock, plus a possible over-allotment of another 300,000 shares. Barclays Capital is the sole book-runner for the offering, according to a press release.